Acomplia and OTC orlistat for weight loss

There's a lot of buzz about Acomplia and OTC orlistat for weight loss. Both could be approved as early as this summer.

Alli (AL-eye) will be OTC orlistat...half the strength of prescription Xenical.

GlaxoSmithKline hopes to market Alli for short-term use... 6 months or less...in people who are overweight.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote